Poster 44
- May 22, 2023
- 1 min read
Bimekizumab Efficacy by Patient Subgroups in Moderate-to-Severe Hidradenitis Suppurativa: 3-Year Phase 3 Results from BE HEARD EXT
Christopher J. Sayed, Martina L. Porter, Alejandro Molina-Leyva, Jacek C. Szepietowski, Yosuke Ishitsuka, Evelina van Ree, Christina Crater, Tom Vaux, Georgios Kokolakis


